DEF 14A: Scientific Industries, Inc. Announces 2023 Annual Meeting of Stockholders
Proxy Statement
Scientific Industries, Inc. will hold its 2023 Annual Meeting of Stockholders virtually on May 17, 2024, to elect directors and ratify the appointment of its independent auditor.
Summary
- Scientific Industries, Inc. is holding its 2023 Annual Meeting of Stockholders on May 17, 2024, virtually.
- Stockholders will vote to elect two Class C Directors to serve until the 2026 annual meeting.
- The nominees for Class C Director are Christopher Cox and John Nicols.
- Stockholders will also vote to ratify the appointment of Mazars USA LLP as the company's independent registered public accounting firm for the fiscal year ending December 31, 2024.
- The record date for determining stockholders eligible to vote is April 10, 2024.
- As of the record date, there were 10,503,599 shares of Common Stock outstanding, each entitled to one vote.
- The Board of Directors recommends voting FOR the election of the director nominees and FOR the ratification of the auditor appointment.
Sentiment
Score: 7
Explanation: The document is a standard proxy statement, which is generally neutral in tone. The information is presented factually, with recommendations from the Board of Directors. The sentiment is slightly positive due to the routine nature of the items and the absence of any significant negative disclosures.
Positives
- The company is providing stockholders with multiple options for voting, including mail, internet, and telephone.
- The Audit Committee is actively involved in overseeing the company's financial statements and the independence of the auditors.
- The company has a code of ethics in place for its Executive Officers and Directors.
Negatives
- The meeting is being held virtually, which may limit stockholder engagement compared to an in-person meeting.
- Joseph G. Cremonese resigned from the Companys Board of Directors on June 14, 2023.
- Marcus Frampton resigned from the Companys Board of Directors on April 4, 2024.
Risks
- Failure to ratify the appointment of Mazars USA LLP as the independent auditor could require the Board to reconsider the appointment.
- The company's reliance on long-term employment agreements and stock options to retain key executives may present a financial burden.
- A change of control could trigger significant severance payments to executive officers.
Future Outlook
The proxy statement outlines the matters to be considered and voted upon at the Annual Meeting, including the election of directors and the ratification of the independent auditor. The Board of Directors recommends voting in favor of the proposals.
Management Comments
- John A. Moore, Chairman, invites stockholders to attend the Annual Meeting and encourages them to vote promptly.
- The Board of Directors believes that the appointment of Mazars USA LLP is in the best interest of the Company and its stockholders.
Industry Context
Proxy statements are standard documents for publicly traded companies, providing stockholders with information necessary to make informed decisions on key corporate matters. The election of directors and ratification of auditors are routine but important governance procedures.
Comparison to Industry Standards
- The structure of Scientific Industries' board, with classified directors and standing committees, is typical of publicly traded companies of similar size.
- The compensation arrangements for executive officers, including base salary, bonus potential, and stock options, are generally in line with industry practices for small-cap companies.
- The audit fee paid to Mazars USA LLP is within a reasonable range for companies of similar size and complexity.
Management Changes
| Role | Previous Person | New Person | Effective Date | Reason |
|---|---|---|---|---|
| Director | Joseph G. Cremonese | N/A | June 14, 2023 | Resignation |
| Director | Marcus Frampton | N/A | April 4, 2024 | Resignation |
Related Party Transactions
- John Nicols, a Director since March 2024, provides consulting services to the Companys Bioprocessing System segment, which was entered in September 2023.
- The agreement provided that the consultant be paid a monthly retainer fee of $8,000.
- For the year ended December 31, 2023, the Company paid fees of $19,200 and issued 35,000 stock options which vest monthly over the one year period, valued at $114,700 on the grant date using the Black-Scholes-Merton option pricing model.
Stakeholder Impact
- The election of directors and ratification of the auditor directly impact shareholders by influencing the governance and financial oversight of the company.
- Executive compensation decisions affect both shareholders and employees, as they reflect the company's priorities and values.
- The outcome of the Annual Meeting will shape the direction and management of Scientific Industries, Inc., impacting all stakeholders.
Next Steps
- Stockholders are encouraged to vote on the proposals outlined in the proxy statement.
- The company will hold the Annual Meeting on May 17, 2024, to conduct the business described in the proxy statement.
- The Board of Directors will consider the outcome of the votes and take appropriate action.
Key Dates
| Date | Description |
|---|---|
| April 10, 2024 | Record date for determining stockholders entitled to notice of and to vote at the Annual Meeting. |
| April 11, 2024 | Date of the proxy statement. |
| April 19, 2024 | Anticipated mailing date of the proxy statement and annual report to stockholders. |
| May 16, 2024 | Deadline for internet votes (11:59 p.m. Eastern Time). |
| May 17, 2024 | Date of the 2023 Annual Meeting of Stockholders. |
| October 19, 2024 | Deadline for stockholder proposals for the following year's annual meeting. |
| December 31, 2024 | Fiscal year end for which Mazars USA LLP is being considered as the independent auditor. |
| December 31, 2026 | End of term for elected Class C Directors. |
Keywords
Annual Meeting, Proxy Statement, Directors, Auditor, Stockholders, Scientific Industries, Governance, Election, Ratification
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.